2 recruiting, 1 completed, 1 terminated. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Completed 1, Terminated 1 |
| Phase 2 | 2 | Recruiting 2 |
Follow tributyrin: new trials by email Literature Review of tributyrin trials Research Report on tributyrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial Tributyrin, Placebo - Parkinson Disease, Multiple System Atrophy | Phase 1 / Phase 2 | Recruiting | Prabesh Kanel | 15 | 2026-10-01 | 2026-11-05 |
| Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments Tributyrin, Placebo - Parkinson Disease, Parkinson Disease Dementia | Phase 1 / Phase 2 | Recruiting | Prabesh Kanel | 45 | 2025-11-07 | 2026-11-13 |
| Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation tributyrin - Parkinson Disease | Phase 1 | Terminated | Nicolaas Bohnen, MD, PhD | 18 | 2022-07-01 | 2025-01-23 |
| Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors chemotherapy, tributyrin - Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of Maryland, Baltimore | 24 | 1995-08-01 | 2019-11-04 |
Parkinson Disease (3) · Multiple System Atrophy (1) · Prostatic Neoplasms (1) · Supranuclear Palsy, Progressive (1)
Prabesh Kanel (2) · Nicolaas Bohnen, MD, PhD (1) · University of Maryland, Baltimore (1)
United States (4)
Prabesh Kanel, PhD (2) · David A. Van Echo, MD (1) · Nicolaas I Bohnen, MD, PhD (1)